The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olaparib (O) in patients (pts) with colorectal cancer (CRC) with ATM mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
 
Deepti Behl
Consulting or Advisory Role - AAA HealthCare; AstraZeneca; Bristol Myers Squibb Foundation; Ipsen; Janssen Oncology; Lilly; Mirati Therapeutics; Novartis; Signatera
Speakers' Bureau - AstraZeneca; Janssen Oncology
 
Michael Rothe
No Relationships to Disclose
 
Pam K. Mangat
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
No Relationships to Disclose
 
Laura Catherine Farrington
No Relationships to Disclose
 
Oxana V. Crysler
Research Funding - ACCRU (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Elie G. Dib
Other Relationship - Genentech (Inst); Merck (Inst)
 
Herbert Leon Duvivier
Speakers' Bureau - AstraZeneca; Guardant Health; Regeneron
 
Michael J. Hall
Consulting or Advisory Role - Eisai; Natera
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst)
Travel, Accommodations, Expenses - GRAIL
Other Relationship - Caris Life Sciences; Invitae; Myriad Genetics
 
John Stuart Salmon
Stock and Other Ownership Interests - Abbvie; Agenus; Agios; Bluebird Bio; Briacell; Briacell; Bristol-Myers Squibb; Cardiff Oncology
Research Funding - Bayer (Inst)
 
Olatunji B. Alese
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer; QED Therapeutics; Seagen; Taiho Oncology
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corcept Therapeutics (Inst); GlaxoSmithKline (Inst); Hutchison MediPharma (Inst); Ipsen (Inst); MabSpace Biosciences (Inst); PCI Biotech (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst)
 
Alissa S. Marr
No Relationships to Disclose
 
Isa Ngirailemesang
Honoraria - Lilly
Consulting or Advisory Role - Lilly
 
Latha Polavaram
No Relationships to Disclose
 
Ramya Thota
No Relationships to Disclose
 
Eddy Shih-Hsin Yang
Consulting or Advisory Role - AstraZeneca; Bayer; Clovis Oncology; Lilly; Strata Oncology
Research Funding - Clovis Oncology (Inst); Lilly (Inst); Novartis (Inst); Puma Biotechnology (Inst)
 
Raegan O'Lone
No Relationships to Disclose
 
Gina N. Grantham
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Honoraria - AVEO; Bristol-Myers Squibb; Sanofi
 
Richard L. Schilsky
Leadership - Clarified Precision Medicine; Leap Therapeutics
Stock and Other Ownership Interests - EQRx
Consulting or Advisory Role - Bryologyx; Cellworks; EQRx; Illumina; Scandion Oncology; Syapse; Zephyr AI
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)